𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Correlation of human bladder tumor recurrence with changes in clonogenicity of urothelial cells

✍ Scribed by Reynold F. X. Noronha; C. Murray Goodall; Kenneth W. Beagley; O. Bruce Stephens; Linda Horne

Publisher
John Wiley and Sons
Year
1985
Tongue
English
Weight
406 KB
Volume
56
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Cloning of the human uroplakin 1B cDNA a
Cloning of the human uroplakin 1B cDNA and analysis of its expression in urothelial-tumor cell lines and bladder-carcinoma tissue
✍ Jennie L. Finch; John Miller; James O. Aspinall; Prudence A. Cowled πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 French βš– 108 KB πŸ‘ 2 views

The human uroplakin 1B (UPK1B) gene codes for a structural protein which is a terminal differentiation component of the asymmetric unit membrane on the apical surface of the mammalian bladder. UPK1B is a member of the tetraspan family of proteins, many of which have de-regulated patterns of expressi

Tumor markers at the time of recurrence
Tumor markers at the time of recurrence in patients with germ cell tumors
✍ JosΓ© M. Trigo; JosΓ© M. Tabernero; Luis Paz-Ares; JosΓ© L. GarcΓ­a-Llano; JosΓ© Mora πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 75 KB πŸ‘ 2 views

BACKGROUND. ␣-fetoprotein (AFP), human chorionic gonadotropin (HCG), and lactate dehydrogenase (LDH) closely follow the course of germ cell tumors (GCTs) and are widely used for diagnosis, prognosis, and follow-up purposes. The objective of this study was to assess the concordance of tumor markers a

Correlation of CD44S expression in renal
Correlation of CD44S expression in renal clear cell carcinomas with subsequent tumor progression or recurrence
✍ Michael Z. Gilcrease; Manuel Guzman-Paz; Gloria Niehans; David Cherwitz; James B πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 193 KB πŸ‘ 2 views

## BACKGROUND. Recent reports have shown altered expression of CD44 in renal cell carcinomas. However, to the authors' knowledge there are no data correlating CD44 expression in renal cell carcinomas with subsequent tumor progression or recurrence, nor is there information about the presence of pa